Average Co-Inventor Count = 4.53
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (14 from 1,975 patents)
2. Atara Biotherapeutics, Inc. (2 from 5 patents)
3. Santa Maria Biotherapeutics, Inc. (0 patent)
15 patents:
1. 12383572 - Administration of an anti-activin-a compound to a subject
2. 11685770 - Stabilized receptor polypeptides and uses thereof
3. 11541070 - Administration of an anti-activin-A compound to a subject
4. 11542325 - Anti-activin A antibodies and uses thereof
5. 10981999 - Dual receptor antagonistic antigen-binding proteins and uses thereof
6. 10308704 - Isolated nucleic acid molecules encoding stabilized receptor polypeptides and uses thereof
7. 10266598 - Dual receptor antagonistic antigen-binding proteins and uses thereof
8. 10100109 - Anti-activin A antibodies and uses thereof
9. 9610327 - Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
10. 9453080 - Dual receptor antagonistic antigen-binding proteins and uses thereof
11. 9284364 - Isolated nucleic acid molecule encoding a fusion protein comprising an activin receptor
12. 9273114 - Stabilized receptor polypeptides and uses thereof
13. 8999343 - Antibodies that bind myostatin, compositions and methods
14. 8999917 - Variant activin receptor polypeptides and uses thereof
15. 8920798 - Myostatin binding agents, nucleic acids encoding the same, and methods of treatment